{"id":"W2149566497","doi":"10.1056/nejmoa0810652","title":"Comparison of Ustekinumab and Etanercept for Moderate-to-Severe Psoriasis","year":2010,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":851,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Ustekinumab; Medicine; Etanercept; Psoriasis; Psoriasis Area and Severity Index; Clinical endpoint; Internal medicine; Secukinumab; Dermatology; Clearance; Gastroenterology; Adalimumab; Randomized controlled trial; Tumor necrosis factor alpha; Psoriatic arthritis; Urology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002354143,0.0003862357,0.001820822,0.0004475784,0.0001461005,0.0005226539,0.0004691254,0.0008586326,0.003482847],"category_scores_gemma":[0.002906919,0.0002013861,0.001513429,0.0002525734,0.0003955311,0.0005650409,0.0002170232,0.001052463,0.0003727345],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003605302,"about_ca_system_score_gemma":0.0005061735,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002436623,"about_ca_topic_score_gemma":0.0006604532,"domain_scores_codex":[0.9983624,0.001099709,0.0001438644,0.00009889127,0.0001688333,0.0001262603],"domain_scores_gemma":[0.9977962,0.001246728,0.0002555142,0.00009364848,0.00007903112,0.0005289295],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8827055,0.006109516,0.002796003,0.0008318383,0.00176764,0.0000581301,0.00006686727,0.0008389956,0.005961663,0.0002137791,0.0004797047,0.09817046],"study_design_scores_gemma":[0.5211458,0.434119,0.0329189,0.0002575463,0.002208871,0.000370997,0.00009768071,0.001828873,0.002993693,0.0007561517,0.00326741,0.00003522289],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9830314,0.01398345,0.0003620896,0.0002874404,0.0002120435,0.0003508965,0.0001483072,0.000023619,0.001600905],"genre_scores_gemma":[0.9963972,0.002204811,0.0003567826,0.000218552,0.0001959216,0.000132968,0.00010929,0.000003972306,0.0003806108],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003482847,"threshold_uncertainty_score":0.01245004,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02972773026265618,"score_gpt":0.3047776721716203,"score_spread":0.2750499419089641,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}